Anthropometric measures and bladder cancer risk: A prospective study in the EPIC cohort

International Journal of Cancer

Volumn 135, Issue 12, 2014, Pages 2918-2929

  Roswall, Nina ^a   Freisling, Heinz ^b   Bueno de Mesquita, H B ^c,d,e   Ros, Martine ^c   Christensen, Jane ^a   Overvad, Kim ^f   Boutron Ruault, Marie Christine ^g,h,i   Severi, Gianluca ^j   Fagherazzi, Guy ^g,h,i   Chang Claude, Jenny ^k   Kaaks, Rudolf ^k   Steffen, Annika ^l   Boeing, Heiner ^l   Argüelles, Marcial ^m   Agudo, Antonio ⁿ   Sánchez, Maŕa José ^o,p   Chirlaque, Maria Dolores ^p,q   Gurrea, Aurelio Barricarte ^q,r   Amiano, Pilar ^p   Wareham, Nick ^s   Khaw, Kay Tee ^s   Bradbury, Kathryn Erica ^t   Trichopoulou, Antonia ^u,v   Papatesta, Helen Maria ^u   Trichopoulos, Dimitrios ^u,v,w   Palli, Domenico ^x   Pala, Valeria ^y   Tumino, Rosario ^z   Sacerdote, Carlotta ^j,aa   Mattiello, Amalia ^ab   Peeters, Petra H ^d,ac   Ehrnström, Roy ^ad   Brennan, Paul ^b   Ferrari, Pietro ^b   Ljungberg, Börje ^ae   Norat, Teresa ^ac   Gunter, Marc ^ac   Riboli, Elio ^ac   Weiderpass, Elisabete ^af,ag,ah,ai   Halkjær, Jytte ^a   more..

^a DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

^f AARHUS UNIVERSITY   (Denmark)

^g INSERM   (France)

^h UNIVERSITÉ PARIS SACLAY   (France)

ⁱ IGR   (France)

^j Human Genetics Foundation (HuGeF)   (Italy)

^k GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^l GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^m Health Department of the Autonomous Government of Asturias   (Spain)

ⁿ CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^o ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

^p CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^q DEPARTMENT OF EPIDEMIOLOGY   (Spain)

^r INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^s UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^t UNIVERSITY OF OXFORD   (United Kingdom)

^u HELLENIC HEALTH FOUNDATION   (Greece)

^v BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^w HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^x CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^y NATIONAL CANCER INSTITUTE   (Italy)

^z CIVILE M P AREZZO HOSPITAL   (Italy)

^aa UNIVERSITY OF TURIN   (Italy)

^ab UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^ac IMPERIAL COLLEGE LONDON   (United Kingdom)

^ad LUND UNIVERSITY HOSPITAL   (Sweden)

^ae UMEÅ UNIVERSITY   (Sweden)

^af UNIVERSITY OF TROMSØ   (Norway)

^ag CANCER REGISTRY OF NORWAY   (Norway)

^ah KAROLINSKA INSTITUTE   (Sweden)

^ai FOLKHÄLSAN RESEARCH CENTER   (Finland)

more..

Author keywords

Anthropometry; Bladder cancer; Cohort study; Obesity

Indexed keywords

ADULT; AGED; ANTHROPOMETRY; BODY MASS; COMPLICATION; FEMALE; HUMAN; MALE; MIDDLE AGED; OBESITY; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK FACTOR; SMOKING; URINARY BLADDER NEOPLASMS; VERY ELDERLY; WAIST CIRCUMFERENCE; WAIST HIP RATIO; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANTHROPOMETRY; BODY MASS INDEX; FEMALE; HUMANS; MALE; MIDDLE AGED; OBESITY; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; SMOKING; URINARY BLADDER NEOPLASMS; WAIST CIRCUMFERENCE; WAIST-HIP RATIO; YOUNG ADULT;

EID: 84908680767     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28936     Document Type: Article

References (52)

1. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin 2011; 61:69-90.
2. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 2013;49:1374-403.
3. Leppert JT, Shvarts O, Kawaoka K, et al. Prevention of bladder cancer: a review. Eur Urol 2006; 49:226-34.
4. st edn. Washington DC: AICR, 2007.
5. Cogliano VJ, Baan R, Straif K, et al. Preventable exposures associated with human cancers. J Natl Cancer Inst 2011;103:1827-39.
6. Renehan AG, Tyson M, Egger M, et al. Bodymass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008;371:569-78.
7. Moller H, Mellemgaard A, Lindvig K, et al. Obesity and cancer risk: a Danish record-linkage study. Eur J Cancer 1994;30A:344-50.
8. Rapp K, Schroeder J, Klenk J, et al. Obesity and incidence of cancer: a large cohort study of over 145,000 adults in Austria. Br J Cancer 2005;93: 1062-7.
9. Samanic C, Chow WH, Gridley G, et al. Relation of body mass index to cancer risk in 362,552 Swedish men. Cancer Causes Control 2006;17:901-9.
10. Reeves GK, Pirie K, Beral V, et al. Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ 2007;335:1134.
11. Larsson SC, Andersson SO, Johansson JE, et al. Diabetes mellitus, body size and bladder cancer risk in a prospective study of Swedish men. Eur J Cancer 2008;44:2655-60.
12. Haggstrom C, Stocks T, Rapp K, et al. Metabolic syndrome and risk of bladder cancer: prospective cohort study in the metabolic syndrome and cancer project (ME-Can). Int J Cancer 2011;128: 1890-8.
13. Holick CN, Giovannucci EL, Stampfer MJ, et al. Prospective study of body mass index, height, physical activity and incidence of bladder cancer in US men and women. Int J Cancer 2007;120: 140-6.
14. Tripathi A, Folsom AR, Anderson KE. Risk factors for urinary bladder carcinoma in postmenopausal women. The Iowa Women's Health Study. Cancer 2002;95:2316-23.
15. Wolk A, Gridley G, Svensson M, et al. A prospective study of obesity and cancer risk (Sweden). Cancer Causes Control 2001;12:13-21.
16. Samanic C, Gridley G, Chow WH, et al. Obesity and cancer risk among white and black United States veterans. Cancer Causes Control 2004;15: 35-43.
17. Koebnick C, Michaud D, Moore SC, et al. Body mass index, physical activity, and bladder cancer in a large prospective study. Cancer Epidemiol Biomarkers Prev 2008;17:1214-21.
18. Jee SH, Yun JE, Park EJ, et al. Body mass index and cancer risk in Korean men and women. Int J Cancer 2008;123:1892-6.
19. Qin Q, Xu X, Wang X, et al. Obesity and risk of bladder cancer: a meta-analysis of cohort studies. Asian Pac J Cancer Prev 2013;14: 3117-21.
20. Green J, Cairns BJ, Casabonne D, et al. Height and cancer incidence in the Million Women Study: prospective cohort, and meta-analysis of prospective studies of height and total cancer risk. Lancet Oncol 2011;12:785-94.
21. Walter RB, Brasky TM, Buckley SA, et al. Height as an explanatory factor for sex differences in human cancer. J Natl Cancer Inst 2013;105:860-8.
22. La VC, Negri E, Parazzini F, et al. Height and cancer risk in a network of case-control studies from northern Italy. Int J Cancer 1990;45:275-9.
23. Wiren S, Haggstrom C, Ulmer H, et al. Pooled cohort study on height and risk of cancer and cancer death. Cancer Causes Control 2014;25: 151-9.
24. Kaaks R, Slimani N, Riboli E. Pilot phase studies on the accuracy of dietary intake measurements in the EPIC project: overall evaluation of results. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol 1997;26 Suppl 1: S26-S36.
25. Riboli E, Hunt KJ, Slimani N, et al. European prospective investigation into cancer and nutrition (EPIC): study populations and data collection. Public Health Nutr 2002;5:1113-24.
26. Spencer EA, Appleby PN, Davey GK, et al. Validity of self-reported height and weight in 4808 EPIC-Oxford participants. Public Health Nutr 2002;5:561-5.
27. Spencer EA, Roddam AW, Key TJ. Accuracy of self-reported waist and hip measurements in 4492 EPIC-Oxford participants. Public Health Nutr 2004;7:723-7.
28. Haftenberger M, Lahmann PH, Panico S, et al. Overweight, obesity and fat distribution in 50- to 64-year-old participants in the European Prospective Investigation into Cancer and Nutrition (EPIC). Public Health Nutr 2002;5:1147-62.
29. Riboli E, Hunt KJ, Slimani N, et al. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr 2002;5:1113-24.
30. Greenland S. Dose-response and trend analysis in epidemiology: alternatives to categorical analysis. Epidemiology 1995;6:356-65.
31. Greenland S. Avoiding power loss associated with categorization and ordinal scores in dose-response and trend analysis. Epidemiology 1995;6:450-4.
32. Wareham NJ, Jakes RW, Rennie KL, et al. Validity and repeatability of a simple index derived from the short physical activity questionnaire used in the European Prospective Investigationinto Cancer and Nutrition (EPIC) study. Public Health Nutr 2003;6:407-13.
33. World Health Organization. Obesity: Preventing and Managing the Global Epidemic. Geneva: World Health Organization; 2000.
34. st edn. UK: Oxford University Press, 2008.
35. rd edn., 1993.
36. SAS [computer program]. Cary, NC: SAS, 2010.
37. Klipstein-Grobusch K, Kroke A, Boeing H. Reproducibility of self-reported past body weight. Eur J Clin Nutr 1998;52:525-8.
38. Travier N, Agudo A, May AM, et al. Longitudinal changes in weight in relation to smoking cessation in participants of the EPIC-PANACEA study. Prev Med 2012;54:183-92.
39. Smith L, Brinton LA, Spitz MR, et al. Body mass index and risk of lung cancer among never, former, and current smokers. J Natl Cancer Inst 2012;104:778-89.
40. Yang Y, Dong J, Sun K, et al. Obesity and incidence of lung cancer: a meta-analysis. Int J Cancer 2013;132:1162-9.
41. Assaf AR, Parker D, Lapane KL, et al. Are there gender differences in self-reported smoking practices? Correlation with thiocyanate and cotinine levels in smokers and nonsmokers from the Pawtucket Heart Health Program. J Womens Health (Larchmt) 2002;11:899-906.
42. Vartiainen E, Seppala T, Lillsunde P, et al. Validation of self reported smoking by serum cotinine measurement in a community-based study. J Epidemiol Community Health 2002;56:167-70.
43. Gan WQ, Cohen SB, Man SF, et al. Sex-related differences in serum cotinine concentrations in daily cigarette smokers. Nicotine Tob Res 2008;10: 1293-300.
44. nd edn. New York: Oxford University Press, 1998.
45. Zhang Y. Understanding the gender disparity in bladder cancer risk: the impact of sex hormones and liver on bladder susceptibility to carcinogens. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 2013;31:287-304.
46. Key TJ, Appleby PN, Reeves GK, et al. Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst 2003;95:1218-26.
47. Daugherty SE, Lacey JV Jr, Pfeiffer RM, et al. Reproductive factors and menopausal hormone therapy and bladder cancer risk in the NIHAARP Diet and Health Study. Int J Cancer 2013; 133:462-72.
48. Davis-Dao CA, Henderson KD, Sullivan-Halley J, et al. Lower risk in parous women suggests that hormonal factors are important in bladder cancer etiology. Cancer Epidemiol Biomarkers Prev 2011; 20:1156-70.
49. Cantwell MM, Lacey JV Jr, Schairer C, et al. Reproductive factors, exogenous hormone use and bladder cancer risk in a prospective study. Int J Cancer 2006;119:2398-401.
50. McGrath M, Michaud DS, De V, I. Hormonal and reproductive factors and the risk of bladder cancer in women. Am J Epidemiol 2006;163:236-44.
51. Kabat GC, Kim MY, Luo J, et al. Menstrual and reproductive factors and exogenous hormone use and risk of transitional cell bladder cancer in postmenopausal women. Eur J Cancer Prev 2013; 22:409-16.
52. Connor GS, Schofield-Hurwitz S, Hardt J, et al. The accuracy of self-reported smoking: a systematic review of the relationship between selfreported and cotinine-assessed smoking status. Nicotine Tob Res 2009;11:12-24.